September 15, 2026  ·  TruVue Journal

How Much Revenue Is Sitting in Unscheduled Treatment Plans (and Which Provider's Recommendations Never Get Booked)?

How Much Revenue Is Sitting in Unscheduled Treatment Plans (and Which Provider's Recommendations Never Get Booked)?

Most practices are carrying between two and six months of production in unscheduled treatment plans: work that was diagnosed, presented, and then never booked. To size it, pull every treatment plan created in the last 18 months, remove anything completed or scheduled, and total the remaining fee. That number is your cheapest available revenue, because the patient is already acquired and the recommendation is already made.

TruVue is a practice operations intelligence platform (not an EMR) that reads the data already sitting in your practice management system and surfaces exactly which recommendations never got scheduled, and whose. We work with dental, medical, and multi-site specialty practice owners across the United States who want to see operational leakage in dollars instead of guessing at it.

What Exactly Counts as Unscheduled Treatment Plan Revenue?

Unscheduled treatment plan revenue is the total fee value of diagnosed, presented procedures that have no completion date and no future appointment attached. It is not a pipeline projection and it is not a marketing forecast. Every dollar in it represents a clinical recommendation a licensed provider already made and documented.

This category is structurally different from the leakage most owners chase. Revenue leakage in healthcare is broadly defined as legitimately earned revenue that a provider never captures, whether through denied claims, uncollected balances, or clinical evidence that existed in the record but was never surfaced or acted on in time, as HiLabs describes in its work on clinical data intelligence. Unscheduled treatment is the purest version of that last category: the evidence is in the chart, and nobody moved it forward.

How to Calculate the Number in Under an Hour

Do this once and you will have a single dollar figure. Most owners are surprised it is larger than their entire annual marketing spend.

Why Is Unscheduled Treatment the Cheapest Revenue in the Practice?

Every other growth lever carries acquisition cost. New patient marketing costs money per lead. Adding chair time or provider hours costs payroll. Renegotiating contracts costs months. Unscheduled treatment costs a phone call and a handoff step.

The patient has already walked in, already consented to an exam, already heard the diagnosis. The only missing step is a booked appointment. Compare that to the cost of an empty slot: as Orva's analysis of no-show economics points out, clinics watch the same gaps recur for years without ever calculating what the empty slots actually cost. The same blindness applies to unscheduled treatment, except the unscheduled version has no marketing cost attached to it at all.

How Do You Measure Case Acceptance Rate by Provider?

A practice-wide case acceptance rate of 62 percent tells you nothing actionable. It averages a provider at 81 percent with a provider at 44 percent and hands you a number you cannot coach against.

Segmenting reports is the whole game. As Teero notes in its guide to measuring case acceptance, tracking acceptance by provider, treatment type, and patient demographic is what reveals coaching opportunities, pricing resistance, and communication gaps. Teero also warns against the two most common ways practices inflate the number: counting scheduled procedures as completed, and failing to log declines at all. Missing data creates blind spots, and blind spots are where unscheduled treatment plan revenue hides.

The Four Cuts That Actually Change Behavior

Note that most practice management systems will not do this for you. MGE Management Experts observes that tracking a true case acceptance rate typically has to be done manually by the owner, office manager, or treatment coordinator, which is precisely why it rarely gets done consistently, and precisely why operations intelligence exists.

What Do You Actually Change Once You Have the Numbers?

The answer is never "sell harder." It is a specific process change tied to a specific gap.

Fix the handoff, not the pitch

If acceptance drops when a coordinator presents alone, change the choreography: the provider states the recommendation, walks the patient to the coordinator, restates it in one sentence, then leaves. That single 30-second step is the highest-yield change most practices never make.

Put financing in front of the high-fee cases only

Payment options are now an expectation rather than a perk. Finmkt reports that practices offering financing often see a 20 to 30 percent increase in acceptance on larger treatment plans, and that the American Dental Association encourages discussing financing to improve treatment acceptance. Target it at the treatment types where your by-type report shows collapse.

Build a treatment plan follow up cadence with an owner's name on it

Assign one person, give them a weekly worklist sorted by fee value and plan age, and hold a 15-minute review of outcomes. Follow up without an accountable owner is a wish, not a process.

Hard-stop the exit

No patient leaves without either a booked appointment or a documented decline with a reason. Clinical and financial hard stops before the patient exits are the same discipline the peer-reviewed revenue cycle management literature in PMC recommends applying upstream of scheduling. Undocumented ambiguity is what turns a diagnosis into a dead plan.

See Your Unscheduled Treatment Before Your Next Partner Meeting

TruVue connects to the systems you already run and returns a dollar-sized view of unscheduled treatment plan revenue, case acceptance rate by provider, acceptance by treatment type, and the follow up work that never happened. No chart migration, no EMR replacement. Request a TruVue demo and see what is already sitting in your practice.

Frequently Asked Questions

What is unscheduled treatment plan revenue?

Unscheduled treatment plan revenue is the total fee value of diagnosed, presented procedures in your practice management system that have no completion date and no future appointment attached. It represents recommendations a provider already made that were never booked, making it the lowest-cost revenue available because the patient is already acquired.

How do you calculate how much revenue is sitting in unscheduled treatment plans?

Pull all treatment plans created in the last 18 months, remove completed procedures, scheduled procedures, transferred patients, and documented declines, then total the remaining fee and multiply by your actual collection rate. Segment the result into zero to 90 days, 91 to 365 days, and over one year to separate scheduling problems from trust problems.

Why should you track case acceptance rate by provider instead of practice-wide?

A practice-wide rate averages a high performer with a struggling one and hides the gap you can actually coach. Tracking case acceptance by provider, treatment type, and presenter reveals whether the issue is communication skill, fee resistance, or a broken handoff, so the fix becomes a specific conversation rather than a generic push to sell more.

How often should a practice run treatment plan follow up?

Run a weekly worklist sorted by fee value and plan age, with one accountable owner and a 15-minute outcome review. Plans under 90 days old convert best because the diagnosis is still fresh in the patient's mind. Plans older than 18 months should be re-diagnosed rather than chased.

Does offering financing improve treatment acceptance?

Yes, particularly on larger cases. Practices that offer financing often see a 20 to 30 percent increase in acceptance for larger treatment plans, and the American Dental Association encourages discussing financing to improve acceptance. Target financing conversations at the treatment types where your by-type acceptance report shows the steepest drop.

See it in your own practice.

TruVue connects the systems you already run into one clear view, from first inquiry to lifetime patient.

Request a Demo

← Back to The Journal